Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.

Sanofi ( NASDAQ: SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, ...

Sanofi is closer to selling a 50% controlling stake in the consumer health business, Opella to private equity Clayton ...

The AdNews Agency Of The Year Award 2024 winners have been revealed. The awards were judged by senior marketers and CMOs from ...

announced Wednesday that it has signed the share purchase agreement for the sale of a 50% controlling stake in its consumer healthcare business, Opella, to private equity firm CD&R. In October ...

2% stake in Opella, with Sanofi remaining a significant ... We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives.

Sanofi and CD&R sign Opella share purchase agreement Paris, February 19, 2025. Following completion of the required social and corporate procedures, Sanofi and CD&R announce today they have signed ...

The sale of Sanofi's controlling stake in health business Opella is expected to close in the second quarter at the earliest, completing its transition into a pure-play drug and vaccine manufacturer.